DC Global Ventures
Overview
Decheng Capital is a global life sciences investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth-stage healthcare companies with a strong market presence.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cellares | Jun 2026 | Series D | Co-investor |
| Polares Medical | Mar 2026 | Series C | Lead |
| Solve Therapeutics | Nov 2025 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DC Global Ventures based?
DC Global Ventures is headquartered in Menlo Park, California, United States.
When was DC Global Ventures founded?
DC Global Ventures was founded in 2012.
How many portfolio companies does DC Global Ventures have?
DC Global Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in DC Global Ventures's portfolio?
Portfolio companies visible on Caplight include Cellares, Polares Medical, Solve Therapeutics.
What was DC Global Ventures's most recent investment shown here?
DC Global Ventures's most recent investment in this portfolio sample was in Cellares in 2026.
What sectors does DC Global Ventures focus on?
DC Global Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does DC Global Ventures focus on?
DC Global Ventures typically invests at the Late stage.
What is DC Global Ventures's AUM?
DC Global Ventures's assets under management are estimated between $2.7B and $2.7B.